|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
IT1232939B
(it)
|
1987-11-06 |
1992-03-10 |
Opocrin Spa |
Eparan solfato caratterizzato da elevata attivita' antitrombotica, elevata biodisponibilita', assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche
|
|
US4865870A
(en)
|
1988-07-07 |
1989-09-12 |
Becton, Dickinson And Company |
Method for rendering a substrate surface antithrombogenic
|
|
PT93847A
(pt)
|
1989-04-24 |
1990-11-20 |
Harvard College |
Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
|
|
US5378829A
(en)
|
1990-04-23 |
1995-01-03 |
Akzo N.V. |
Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
|
|
AU2561792A
(en)
|
1991-09-06 |
1993-04-05 |
Children's Medical Center Corporation |
Cell-type specific heparan sulfate proteoglycans and their uses
|
|
IT1260137B
(it)
|
1992-04-17 |
1996-03-28 |
Alfa Wassermann Spa |
Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
|
|
JP3818676B2
(ja)
|
1994-07-22 |
2006-09-06 |
生化学工業株式会社 |
ヘパラン硫酸６−ｏ−硫酸基転移酵素
|
|
IT1271057B
(it)
|
1994-11-04 |
1997-05-26 |
Inalco Spa |
Polisaccaridi aventi un elevato contenuto di acido iduronico
|
|
JP3672359B2
(ja)
|
1995-07-24 |
2005-07-20 |
生化学工業株式会社 |
ヘパラン硫酸 ２−ｏ−硫酸基転移酵素
|
|
JP3713276B2
(ja)
|
1995-09-29 |
2005-11-09 |
バイオマリン ファーマシューティカル インコーポレイテッド |
炎症反応の軽減のためのヘパリナーゼの使用
|
|
US5935824A
(en)
|
1996-01-31 |
1999-08-10 |
Technologene, Inc. |
Protein expression system
|
|
US6861254B1
(en)
|
1997-10-24 |
2005-03-01 |
Massachusetts Institute Of Technology |
Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor
|
|
US7307159B2
(en)
|
2001-05-08 |
2007-12-11 |
The Board Of Regents Of The University Of Oklahoma |
Heparin/heparosan synthase from P. multocida and methods of making and using same
|
|
US8088604B2
(en)
|
1998-04-02 |
2012-01-03 |
The Board Of Regents Of The University Of Oklahoma |
Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
|
|
US6624141B1
(en)
|
1999-03-17 |
2003-09-23 |
The Regents Of The University Of Michigan |
Protamine fragment compositions and methods of use
|
|
US6255088B1
(en)
|
1999-05-11 |
2001-07-03 |
The Scripps Research Institute |
Enzymatic sulfation of biomolecules
|
|
US7101859B2
(en)
*
|
2000-01-10 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Use of lipid conjugates in the treatment of diseases
|
|
WO2002004471A1
(fr)
|
2000-07-07 |
2002-01-17 |
Seikagaku Corporation |
Fractions oligosaccharidiques d'acide hyaluronique et medicament les contenant
|
|
US8067196B2
(en)
|
2001-03-28 |
2011-11-29 |
Massachusetts Institute Of Technology |
6-O sulfated polysaccharides and methods of preparation thereof
|
|
US7300922B2
(en)
|
2001-05-25 |
2007-11-27 |
Duke University |
Modulators of pharmacological agents
|
|
WO2003018598A2
(en)
|
2001-08-30 |
2003-03-06 |
University College Dublin |
Monosaccharide derivatives
|
|
WO2004005475A2
(en)
|
2002-07-05 |
2004-01-15 |
University Of North Carolina At Chapel Hill |
Purified and isolated heparan sulfate 3-o-sulfotransferase isoform 5 nucleic acids and polypeptides and therapeutic and screening methods using same
|
|
GB0216861D0
(en)
|
2002-07-19 |
2002-08-28 |
Univ Birmingham |
Saccharide libraries
|
|
AU2003262794A1
(en)
|
2002-08-23 |
2004-03-11 |
Neose Technologies, Inc. |
Total synthesis of heparin
|
|
WO2005014619A2
(en)
|
2003-03-28 |
2005-02-17 |
Thomas Jefferson University |
Heparin-binding peptides and uses thereof
|
|
ATE502062T1
(de)
|
2003-10-24 |
2011-04-15 |
3M Innovative Properties Co |
Wässrige dispersionen von polytetrafluorethylenteilchen
|
|
US7655445B2
(en)
|
2003-11-12 |
2010-02-02 |
Massachusetts Institute Of Technology |
Methods for synthesis of sulfated saccharides
|
|
WO2005118609A2
(en)
*
|
2004-05-26 |
2005-12-15 |
California Institute Of Technology |
Small molecule stimulators of neuronal growth
|
|
WO2006015171A2
(en)
*
|
2004-07-28 |
2006-02-09 |
The Texas A & M University System |
Use of glycosoaminoglycans for the prevention and treatment of sepsis
|
|
WO2006124801A2
(en)
|
2005-05-12 |
2006-11-23 |
The University Of North Carolina At Chapel Hill |
Enzymatic synthesis of sulfated polysaccharides
|
|
CN101495517B
(zh)
|
2006-05-25 |
2012-10-10 |
莫曼塔医药品有限公司 |
低分子量肝素及其用途
|
|
WO2009014715A2
(en)
|
2007-07-23 |
2009-01-29 |
The University Of North Carolina At Chapel Hill |
Enzymatic synthesis of sulfated polysaccharides without iduronic acid residues
|
|
ES2567079T3
(es)
|
2007-11-02 |
2016-04-19 |
Momenta Pharmaceuticals, Inc. |
Composiciones de polisacáridos que no son anticoagulantes
|
|
EP2364165B1
(en)
|
2008-11-14 |
2018-01-03 |
Portola Pharmaceuticals, Inc. |
Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
|
|
CA2750188C
(en)
*
|
2009-02-02 |
2016-11-29 |
Otsuka Chemical Co., Ltd. |
Low-molecular polysulfated hyaluronic acid derivative and compositions containing same
|
|
BRPI1010516A2
(pt)
|
2009-04-09 |
2015-08-25 |
Univ North Carolina |
Métodos de tratamento de edema relacionados à isquemia-reperfusão
|
|
US20110054236A1
(en)
|
2009-08-25 |
2011-03-03 |
The Regents Of The University Of Michigan |
Compositions and methods for targeting tumors
|
|
EP2480237A1
(en)
|
2009-09-23 |
2012-08-01 |
Momenta Pharmaceuticals, Inc. |
Methods of treatment with a low molecular weight heparin composition
|
|
DK2646037T3
(en)
*
|
2010-12-01 |
2019-03-04 |
Univ Australian National |
use of polyanions to inhibit the cytotoxic activity of histones in the treatment of sepsis
|
|
US11203772B2
(en)
|
2010-12-23 |
2021-12-21 |
The University Of North Carolina At Chapel Hill |
Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparins
|
|
TW201309305A
(zh)
|
2011-02-22 |
2013-03-01 |
Rensselaer Polytech Inst |
用於製造生物工程肝素之單一步驟肝素前體之ｎ－去乙醯化作用及解聚合作用
|
|
US8519189B2
(en)
|
2011-06-01 |
2013-08-27 |
University Of British Columbia |
Polymers for reversing heparin-based anticoagulation
|
|
CA2901225C
(en)
|
2013-03-08 |
2023-09-19 |
Csl Behring Gmbh |
Treatment and prevention of remote ischemia-reperfusion injury
|
|
ES2924830T3
(es)
|
2013-06-17 |
2022-10-11 |
Univ North Carolina Chapel Hill |
Moléculas de heparina reversibles
|
|
CN110446511B
(zh)
|
2017-03-10 |
2024-04-02 |
北卡罗来纳大学查珀尔希尔分校 |
短效的基于肝素的抗凝血剂化合物和方法
|
|
WO2019010216A1
(en)
|
2017-07-03 |
2019-01-10 |
The University Of North Carolina At Chapel Hill |
ENZYMATIC SYNTHESIS OF HOMOGENEOUS CHONDROITIN SULFATE OLIGOSACCHARIDES
|
|
JP7495061B2
(ja)
|
2017-11-03 |
2024-06-04 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
抗炎症作用を有する硫酸化オリゴ糖
|
|
WO2021097345A1
(en)
|
2019-11-13 |
2021-05-20 |
The University Of North Carolina At Chapel Hill |
Heparan sulfate (hs) oligosaccharides effect in liver ischemia reperfusion injury
|